The Influence of Sevoflurane on the Antagonism Effect of Neostigmine for Rocuronium-induced Neuromuscular Blockade

Sevoflurane이 Rocuronium의 신경근차단에 대한 Neostigmine의 길항작용에 미치는 영향

Choi, Seung-Ho;Kim, Mi-Kyeong;Lee, Woo-Kyung;Shim, Yon-Hee;Shin, Yang-Sik
최승호;김미경;이우경;심연희;신양식

  • Published : 20050300

Abstract

Background: Some volatile anesthetics prolong the spontaneous recovery from neuromuscular blockade, and decrease the effect of neostigmine administrated for neuromuscular recovery. In addition, these effects differ among each volatile anesthetic. The aim of this study was to examine the effect of sevoflurane on the antagonism effect of neostigmine during the recovery period after administering rocuronium. Methods: Sixty-five adult patients were randomly allocated into 3 groups, using propofol and alfentanil, sevoflurane, and enflurane for the maintenance of anesthesia. Neuromuscular monitoring was performed using accelomyography. Tracheal intubation was performed at the maximum blockade after administering 0.6 mg/kg rocuronium. The infusion of rocuronium was initiated when a twitch was noticed and the infusion rate of rocuronium was determined to maintain a 15$\pm$5% twitch height. The acid-base balance was measured at a constant twitch height, and 20$\mu{g}$/kg neostigmine injection. After neostigmine, the initial twitch height, the maximum twitch height, the onset and duration of neostigmine were measured, and the antagonism effect was calculated as a percentage of the pre-existing twitch depression immediately before administering the neostigmine. Results: The maximum twitch heights and antagonism effects of the Sevoflurane and Propofol groups were larger than that of the Enflurane group and the durations of the neostigmine effect were longer. The rocuronium infusion rate was significantly higher in the Propofol group than in the other groups. Conclusions: The effects of sevoflurane on the antagonism effect and duration of neostigmine were less than enflurane, and there was no difference between sevoflurane and propofol.

Keywords

References

  1. Magorian T, Flannery KB, Miller RD: Comparison of rocuronium, succinylcholine, and vecuronium for rapid sequence induction of anesthesia in adults. Anesthesiology 1993; 79: 913- 8 https://doi.org/10.1097/00000542-199311000-00007
  2. Fuchs-Buder T, Tassonyi E: Intubating conditions and time course of rocuronium-induced neuromuscular block in children. Br J Anaesth 1996; 77: 335-8 https://doi.org/10.1093/bja/77.3.335
  3. Zhou TJ, White PF, Chiu JW, Joshi GP, Dullye KK, Duffy LL, et al: Onset/offset characteristics and intubating conditions of rapacuronium: a comparison with rocuronium. Br J Anaesth 2000; 85: 246-50 https://doi.org/10.1093/bja/85.2.246
  4. Miller DR, Wherrett C, Hull K, Watson J, Legault S: Cumulation characteristics of cisatracurium and rocuronium during continuous infusion. Can J Anesth 2000; 47: 943-9 https://doi.org/10.1007/BF03024863
  5. Vuksanaj D, Fisher DM: Pharmacokinetics of rocuronium in children aged 4-11 years. Anesthesiology 1995; 82: 1104-10 https://doi.org/10.1097/00000542-199505000-00003
  6. Hasfurther DL, Bailey PL: Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin. Can J Anaesth 1996; 43: 617-20 https://doi.org/10.1007/BF03011775
  7. Lowry DW, Mirakhur RK, McCarthy GJ, Carroli MT, McCourt KC: Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998; 87: 936-40 https://doi.org/10.1097/00000539-199810000-00036
  8. Wulf H, Ledowski T, Linstedt D, Proppe D, Sitzlack D: Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. Can J Anaesth 1998; 45: 526-32 https://doi.org/10.1007/BF03012702
  9. Bock M, Klippel K, Nitsche B, Bach A, Martin E, Motsch J: Rocuronium potency and recovery characteristics during steadystate desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000; 84: 43-7 https://doi.org/10.1093/oxfordjournals.bja.a013380
  10. Morita T, Tsukagoshi H, Sugaya T, Saito S, Sato H, Fujita T: Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia. Anesth Analg 1995; 80: 1175-80 https://doi.org/10.1097/00000539-199506000-00019
  11. Baurain MJ, Hoton F, d'Hollander AA, Cantraine FR: Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuroniurn? Br J Anaesth 1996; 77: 496-9 https://doi.org/10.1093/bja/77.4.496
  12. Abdulatif M, Mowafi H, Al-Ghamdi A, El-Sanabary M: Doseresponse relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults. Br J Anaesth 1996; 77: 710-5 https://doi.org/10.1093/bja/77.6.710
  13. Zhou TJ, Tang J, White PF, Jorshi GP, Wender R, Murphy MT, et al: Reversal of rapacuronium block during propofol versus sevoflurane anesthesia. Anesth Analg 2000; 90: 689-93 https://doi.org/10.1097/00000539-200003000-00033
  14. Reid JE, Breslin DS, Mirakhur RK, Hayes AH: Neostigmine an- tagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol. Can J Anaesth 2001; 48: 351-5 https://doi.org/10.1007/BF03014962
  15. McEwin L, Merrick PM, Bevan DR: Residual neuromuscular blockade after cardiac surgery: pancuronium vs rocuronium. Can J Anaesth 1997; 44: 891-5 https://doi.org/10.1007/BF03013167
  16. Gencarelli PJ, Miller RD: Antagonism of vecuronium and pancuronium neuromuscular blockade by neostigmine. Br J Anaesth 1982; 54: 53-6 https://doi.org/10.1093/bja/54.1.53
  17. Magorian TT, Lynam DP, Caldwell JE, Miller RD: Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium induced neuromuscular blockade? Anesthesiology 1990; 73: 410-4 https://doi.org/10.1097/00000542-199009000-00008
  18. Miller RD, Roderick LL: Acid-base balance and neostigmine antagonism of pancuronium neuromuscular blockade. Br J Anaesth 1978; 50: 317-23 https://doi.org/10.1093/bja/50.4.317